PIGM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.538000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.922200E-01
Normal-vs-Stage2
7.161200E-01
Normal-vs-Stage3
4.767700E-02
Normal-vs-Stage4
4.507800E-01
Stage1-vs-Stage2
2.077000E-01
Stage1-vs-Stage3
2.069600E-02
Stage1-vs-Stage4
5.206800E-01
Stage2-vs-Stage3
5.498400E-03
Stage2-vs-Stage4
4.510400E-02
Stage3-vs-Stage4
1.205420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.495200E-01
Normal-vs-AfricanAmerican
2.353400E-01
Normal-vs-Asian
7.074600E-01
Caucasian-vs-AfricanAmerican
1.420190E-02
Caucasian-vs-Asian
8.567700E-02
AfricanAmerican-vs-Asian
4.032400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.283600E-01
Normal-vs-Female
7.990000E-01
Male-vs-Female
7.535200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.534200E-01
Normal-vs-Age(41-60Yrs)
8.302400E-01
Normal-vs-Age(61-80Yrs)
7.310200E-01
Normal-vs-Age(81-100Yrs)
7.488200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.605000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.404200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.079600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.607200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.289600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.897600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.709200E-01
Normal-vs-Daily Drinker
1.128390E-01
Normal-vs-Weekly Drinker
8.958400E-01
Normal-vs-Occasional Drinker
9.924000E-01
Normal-vs-Social Drinker
9.756200E-01
Non Drinker-vs-Daily Drinker
3.758300E-02
Non Drinker-vs-Weekly Drinker
8.135800E-01
Non Drinker-vs-Occasional Drinker
5.210000E-01
Non Drinker-vs-Social Drinker
6.100600E-01
Daily Drinker-vs-Weekly Drinker
8.882000E-02
Daily Drinker-vs-Occasional Drinker
4.277200E-03
Daily Drinker-vs-Social Drinker
1.237850E-02
Weekly Drinker-vs-Occasional Drinker
7.771400E-01
Weekly Drinker-vs-Social Drinker
8.429400E-01
Occasional Drinker-vs-Social Drinker
9.415200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.069800E-02
Normal-vs-Grade 2
3.158200E-03
Normal-vs-Grade 3
9.757100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.900000E-01
Grade 1-vs-Grade 3
6.636200E-01
Grade 1-vs-Grade 4
2.069800E-02
Grade 2-vs-Grade 3
2.646400E-01
Grade 2-vs-Grade 4
3.158200E-03
Grade 3-vs-Grade 4
9.757100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.915200E-01
Normal-vs-NonDiabetic
7.330000E-01
Diabetic-vs-NonDiabetic
9.543900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.671400E-01
Normal-vs-NoPancreatitis
6.501200E-01
Pancreatitis-vs-NoPancreatitis
6.911400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.361600E-01
Normal-vs-N1
6.336600E-01
N0-vs-N1
6.337600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.102800E-01
Normal-vs-TP53-NonMutant
6.851400E-01
TP53-Mutant-vs-TP53-NonMutant
5.269000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
